James Harvey Carter
Assistant Professor of Neurosurgery

Investigator on the following Studies/Protocols:

Study Title: "A multicenter Phase II Study of TP-38 in those patients with glioblastoma multiforme who have recurred or progressed after previous resection and radiation therapy and are scheduled for gross total resection"

Study Title: "A Phase II Trial of Gliodal PWS06-Benzylquanine for patients with recurrent glioblastoma mulfiforme"

Study Title: "T-regs in blood underlying tumor escape"

Study Title: "Specimen collection in patients treated up front for malignant astrocytoma"

Study Title: A Complementary Trial of an Immunotherapy Vaccine Against Tumor-Specific EGFRvIII

Study Title: Specimen Collection on Patients Treated Up Front for Malignant Astrocytomas

Study Title: Phase III Randomized Evaluation of Convection Enhanced Delivery of IL13-PE38QQR Compared to Gliadel Wafer with Survival Endpoint in Glioblastoma Multiforme Patients At First Recurrence

Study Title: Phase II Study of 131I-Labeled Anti-tenascin Murine Monoclonal Antibody 81C6 (mu81C6) Administered to Deliver a Targeted Radiation Boost Dose of 44Gy to the Surgically Created Cystic Resection Cavity Perimeter Followed by Conventional External Beam Radiotherapy and Temozolomide for Patients with Newly Diagnosed Glioblastoma Multiforme

Current Appointments & Affiliations

Contact Information

  • 4518 Busse Bldg, Durham, NC 27710
  • Box 3807 Med Ctr, Durham, NC 27710

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.